- Home
- ITRM vs NOM Comparison
ITRM vs NOM Comparison
Compare ITRM & NOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITRM
- NOM
- Stock Information
- Founded
- ITRM 2015
- NOM 1993
- Country
- ITRM Ireland
- NOM United States
- Employees
- ITRM N/A
- NOM N/A
- Industry
- ITRM Biotechnology: Pharmaceutical Preparations
- NOM Investment Managers
- Sector
- ITRM Health Care
- NOM Finance
- Exchange
- ITRM Nasdaq
- NOM Nasdaq
- Market Cap
- ITRM 24.7M
- NOM 25.3M
- IPO Year
- ITRM 2018
- NOM N/A
- Fundamental
- Price
- ITRM $1.37
- NOM $10.63
- Analyst Decision
- ITRM Strong Buy
- NOM
- Analyst Count
- ITRM 1
- NOM 0
- Target Price
- ITRM $5.00
- NOM N/A
- AVG Volume (30 Days)
- ITRM 7.1M
- NOM 6.9K
- Earning Date
- ITRM 11-14-2024
- NOM 01-01-0001
- Dividend Yield
- ITRM N/A
- NOM 3.39%
- EPS Growth
- ITRM N/A
- NOM N/A
- EPS
- ITRM N/A
- NOM N/A
- Revenue
- ITRM N/A
- NOM N/A
- Revenue This Year
- ITRM N/A
- NOM N/A
- Revenue Next Year
- ITRM N/A
- NOM N/A
- P/E Ratio
- ITRM N/A
- NOM N/A
- Revenue Growth
- ITRM N/A
- NOM N/A
- 52 Week Low
- ITRM $0.81
- NOM $8.52
- 52 Week High
- ITRM $2.50
- NOM $10.48
- Technical
- Relative Strength Index (RSI)
- ITRM 54.25
- NOM 50.43
- Support Level
- ITRM $1.25
- NOM $10.45
- Resistance Level
- ITRM $1.61
- NOM $10.68
- Average True Range (ATR)
- ITRM 0.14
- NOM 0.16
- MACD
- ITRM 0.00
- NOM 0.03
- Stochastic Oscillator
- ITRM 46.67
- NOM 84.20
About ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a clinical-stage pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. Its sulopenem program has the potential to offer a solution to the problem of antibiotic resistance and the toxicity limitations of existing agents. The company operates as a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.
About NOM Nuveen Missouri Quality Municipal Income Fund
Nuveen Missouri Quality Municipal Income Fund is a diversified, closed-end management investment company operating in United States. The Fund's primary investment objective is current income exempt from both regular federal income taxes and Missouri state income taxes; its secondary investment objective is the enhancement of portfolio value. The fund invests in municipal securities as well as floating rate securities as well as derivatives such as futures, options and swap contracts to the necessary extent. Nuveen Fund Advisors, LLC acts as an investment adviser of the company.